The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological...
In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...
Introduction. Tenckhoff catheter exit site infection (ESI) occurs in 0.05–1.05 cases per patient per year and is a risk factor of termination of peritoneal dialysis (PD). Objective of the work. To evaluate the efficacy o...
EP ID EP421434
DOI 10.22141/2307-1257.7.4.2018.148514
Views 60
Downloads 0
How To Cite
(2018). Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Нирки, 7(4),
261-268. https://europub.co.uk/articles/-A-421434
Sign In Europub
For faster login or register use your social account.
Effectiveness of pantocrinum in the complex treatment of chronic kidney disease
The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological...
The Experience of Combination Phytotherapy in Patients with Urethrolithiasis
In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...
Clinical Practice Guideline Peritoneal Dialysis in Adults and Children, 2017 Summary of Clinical Practice Guidelines for Peritoneal Dialysis
.
Clinical case of successful treatment of Goodpasture syndrome with rituximab
.
Results of Differential Treatment of Tenckhoff Catheter Exit Site/Tunnel Infection during Peritoneal Dialysis in Patients with End-Stage Chronic Kidney Disease
Introduction. Tenckhoff catheter exit site infection (ESI) occurs in 0.05–1.05 cases per patient per year and is a risk factor of termination of peritoneal dialysis (PD). Objective of the work. To evaluate the efficacy o...